Match tier Confirmed
Presence Current · Arkansas
Last published 2026
Sources OpenAlex · ORCID
Refreshed 2026-08-20

Z. Ryan Tian

Affiliation confirmed via AI analysis of OpenAlex, ORCID, and web sources.

Federal Grant PI High Impact

Professor

Also affiliated: Hebei Medical University (2021); Jiangsu University (2019–2020); Uppsala University Hospital (2012); University of Connecticut (1996–1998); Emory University (2020); Xinjiang Medical University (2013–2023); Shenyang University of Technology (2025); Tianjin University (2011); University of St Andrews (2017); University of New Mexico (2006–2007); Capital Medical University (2025); Lehigh University (2014–2019); Jilin University (2006); China Academy of Space Technology (2023); Chinese Academy of Medical Sciences & Peking Union Medical College (2020–2024); Changchun Normal University (2025); Peking University (2023); Missouri University of Science and Technology (2013); Hubei University of Chinese Medicine (2025); Beijing Jiaotong University (2025–2026); Chengdu University of Information Technology (2023); China-Japan Friendship Hospital (2020–2024); First Affiliated Hospital of Xinjiang Medical University (2013–2023); Guangzhou Sport University (2021); Beijing Forestry University (2016); University of California San Diego (2020); Sichuan Agricultural University (2025); Third Hospital of Hebei Medical University (2021); Chinese Academy of Inspection and Quarantine (2019–2021); Rongo University (2021); Sandia National Laboratories (2006); National Space Science Center (2015); Tianjin Fourth Central Hospital (2023); National Clinical Research (2020–2024); Ningxia Medical University (2025); The Affiliated Yongchuan Hospital of Chongqing Medical University (2006); Government of Jilin Province (2025); Ningxia Medical University General Hospital (2025); Institute of Hematology & Blood Diseases Hospital (2020); Center for Life Sciences (2022); Center for Forensic Mental Health, Chiba University (2018–2021); State Key Laboratory of Optoelectronic Materials and Technology (2006); State Key Laboratory of Inorganic Synthesis and Preparative Chemistry (2006); Tianjin Medical University (2023); Putian University (2002); East China Normal University (2022–2024); Chongqing Medical University (2006); Tsinghua University (2006–2022)

Faculty Researcher

31 h-index 256 pubs 4,312 cited

Upstream record may be merged OpenAlex, the source of these figures, lists 50 institutions in 6 countries for this author record — a pattern that usually means it combines several researchers with similar names. The totals above may include work by other people.

  • Neuroprotective Agents
  • Humans
  • Animals
  • Nanowires
  • Male
  • Rats
  • Brain
  • Amino Acids
  • Drug Delivery Systems
  • Spinal Cord Injuries
  • Alzheimer Disease
  • Parkinson Disease
  • Mesenchymal Stem Cells
  • Titanium
  • Brain Injuries, Traumatic

Biography and Research Information

OverviewAI-generated summary

Z. Ryan Tian's research focuses on the development and application of novel nanomaterials for various biomedical and energy-related applications. He has published extensively on topics including the use of nanoparticles for drug delivery, neuroprotection, and the development of advanced materials for energy conversion and storage. His work with manganese nanoparticles has investigated their impact on the blood-brain barrier and associated neurological functions. Additionally, Tian has explored the potential of hydrogen-substituted graphdiyne and hybrid perovskites in photoelectrochemical water reduction and carbon dioxide reduction, respectively.

His research group at the University of Arkansas at Fayetteville is active in exploring advanced materials, including nanowires and hydrogel electrolytes, for applications such as stretchable Li-ion batteries. Tian's work also extends to the commercialization of research, as evidenced by his Principal Investigator role on an NSF I-Corps grant for developing a real-time, wireless SARS-CoV-II detector. With a significant publication record (253 publications) and a notable h-index of 31, his scholarship has been recognized as high-impact.

Tian collaborates with several researchers at the University of Arkansas at Fayetteville, including Mark Lanoue, Asya Ozkızılcık, Parker Cole, and Savannah Thornburgh, contributing to a diverse research network. His work is supported by federal grants, including a $50,000 NSF award.

Metrics

  • h-index: 31
  • Publications: 256
  • Citations: 4,312

Selected Publications

  • Retraction Note: Cerebrolysin Attenuates Exacerbation of Neuropathic Pain, Blood-Spinal Cord Barrier Breakdown and Cord Pathology Following Chronic Intoxication of Engineered Ag, Cu or Al (50–60 nm) Nanoparticles (2026)
  • Retraction Note to: Timed Release of Cerebrolysin Using Drug-Loaded Titanate Nanospheres Reduces Brain Pathology and Improves Behavioral Functions in Parkinson’s Disease (2026)
  • Retraction Note to: Nanowired Delivery of Growth Hormone Attenuates Pathophysiology of Spinal Cord Injury and Enhances Insulin-Like Growth Factor-1 Concentration in the Plasma and the Spinal Cord (2026)
  • Surface properties and in-vitro bioactivity studies of TiO2 nanowire doped transition metal (M=Fe, Co, and Mn) (2026)
  • Novel Nanomaterials for Developing Bone Scaffolds and Tissue Regeneration (2025)
    Nanomaterials 22 citations DOI OpenAlex
  • Hydrothermally doping valve metal Nb into Titanate nanofibers structure for potentially engineering bone tissue (2024)
    Nano and Medical Materials 1 citation DOI OpenAlex
  • Efficient Photocatalytic Core–Shell Synthesis of Titanate Nanowire/rGO (2024)
    Catalysts 6 citations DOI OpenAlex
  • Mo-doped titanate nanofibers from hydrothermal syntheses for improving bone scaffold (2024)
    Characterization and Application of Nanomaterials 7 citations DOI OpenAlex
  • Hydrothermal synthesis of valve metal Ta-doped titanate nanofibers for potentially engineering bone tissue (2024)
    Characterization and Application of Nanomaterials 5 citations DOI OpenAlex
  • Hydrothermal synthesis of valve metal Zr-doped titanate nanofibers for bone tissue engineering (2023)
    Nano and Medical Materials 6 citations DOI OpenAlex
  • Spinal cord injury induced exacerbation of Alzheimer's disease like pathophysiology is reduced by topical application of nanowired cerebrolysin with monoclonal antibodies to amyloid beta peptide, p-tau and tumor necrosis factor alpha (2023)
    International review of neurobiology 1 citation DOI OpenAlex
  • Co-administration of dl-3-n-butylphthalide and neprilysin is neuroprotective in Alzheimer disease associated with mild traumatic brain injury (2023)
    International review of neurobiology 1 citation DOI OpenAlex
  • Nicotine neurotoxicity exacerbation following engineered Ag and Cu (50–60 nm) nanoparticles intoxication. Neuroprotection with nanowired delivery of antioxidant compound H-290/51 together with serotonin 5-HT3 receptor antagonist ondansetron (2023)
    International review of neurobiology 5 citations DOI OpenAlex
  • Sleep deprivation enhances amyloid beta peptide, p-tau and serotonin in the brain: Neuroprotective effects of nanowired delivery of cerebrolysin with monoclonal antibodies to amyloid beta peptide, p-tau and serotonin (2023)
    International review of neurobiology 1 citation DOI OpenAlex
  • Nanowired delivery of antibodies to tau and neuronal nitric oxide synthase together with cerebrolysin attenuates traumatic brain injury induced exacerbation of brain pathology in Parkinson’s disease (2023)
    International review of neurobiology 2 citations DOI OpenAlex

View all publications on OpenAlex →

Federal Grants 1 $50,000 total

Collaboration Network

83 Collaborators 29 Institutions 11 Countries

Top Collaborators

Similar Researchers

Based on overlapping research topics